Frances Oldham Kelsey: Biography, Achievements & Lasting Legacy
Who Was Frances Oldham Kelsey?
Frances Kathleen Oldham Kelsey (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American pharmacologist and physician who had a 45-year career with the U.S. Food and Drug Administration (FDA). As a reviewer, she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects. Kelsey's career intersected with the passage of laws strengthening FDA oversight of pharmaceuticals. Kelsey was the first woman to receive a PhD in pharmacology and the second woman to receive the President's Award for Distinguished Federal Civilian Service, awarded to her by John F. Kennedy in 1962.
Key Facts
- Born: July 24, 1914 in Cobble Hill, British Columbia, Canada
- Died: 2015
- Field: Medicine
- Awards: President's Award for Distinguished Federal Civilian Service (1962)
Legacy and Impact
The influence of Frances Oldham Kelsey extends far beyond her own lifetime. She fundamentally shaped healthcare and human longevity, and her medical discoveries and treatments remain foundational to this day.
Though she passed away in 2015, her ideas continue to be studied, debated, and built upon by scholars and practitioners worldwide.
Frances Oldham Kelsey remains one of the most celebrated minds to emerge from Canada, a testament to the rich intellectual heritage of the region.
Notable Geniuses from Canada
Canada has produced many remarkable minds. Alongside Frances Oldham Kelsey:
View all geniuses from Canada →
Discover more brilliant minds in Medicine
Explore Medicine GeniusesRelated Articles
Explore More
Read the full profile of Frances Oldham Kelsey
View Frances Oldham Kelsey's Profile →
